Advertisement

Gastroenterologia Japonica

, Volume 28, Issue 2, pp 242–248 | Cite as

Effects of cytokines on HLA class I antigen expression on Huh6 and HB611 cells

  • Takahiro Towata
  • Norio Hayashi
  • Kazuhiro Katayama
  • Tetsuo Takehara
  • Eiji Miyoshi
  • Yuko Kawanishi
  • Keiji Ueda
  • Akinori Kasahara
  • Hideyuki Fusamoto
  • Takenobu Kamada
Liver, Pancereas, and Biliary Tract
  • 23 Downloads

Summary

This study investigated the expression of HLA class I antigens on Huh6 and HB611 cells induced by interferon (IFN)-α, IFN-γ, tumor necrosis factor (TNF)-α and interleukin (IL)-lβ. All of these cytokines induced the antigens on both cells in a dose-dependent manner, with IFNs inducing much more expression than TNF-α or IL-1β. We have already reported that protein kinase C (PKC) is involved in the antigen expression induced by IFN-γ on Huh6 cells. The antigen expression induced by IFN-α was also blocked by a PKC inhibitor, H-7. However, the antigen expression by TNF-α or IL-1β was not inhibited by H-7, by a protein kinase A inhibitor, HA1004, nor by a calmodulin antagonist, W-7. These results suggested that PKC, Ca2+-calmodulin, and cAMP are not involved in the induction of HLA class I antigens on both cells by TNF-a and IL-1β. We concluded that TNF-a and IL-1β induced much less expression of HLA class I antigens on both cells than IFNs and that this might be because the signaling pathway by TNF-α and IL-1β differed from that by IFNs.

Key words

interferon tumor necrosis factor interleukin-1 HLA class I antigen Huh6 HB611 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Trincheri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunology Today 1985;6:131–135.CrossRefGoogle Scholar
  2. 2.
    Le J, Vilcek J. Biology of disease. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 1987;5:234–248.Google Scholar
  3. 3.
    Oppenheim JJ, Kovacs EJ, Matsushima K, et al. There is more than one interleukin 1. Immunology Today 1986;7:45–56.CrossRefGoogle Scholar
  4. 4.
    Durandy A, Virelizier JL, Griscelli C. Enhancement by interferon of membrane HLA class I antigens in patients with combined immunodeficiency with defective HLA expression. Clin Exp Immunol 1983;52:173–178.PubMedGoogle Scholar
  5. 5.
    Pignatelli M, Waters J, Brown D, et al. HLA class I antigen on the hepatocyte membrane during recovery from acute hepatitis B infection. Hepatology 1986;6:349–353.PubMedCrossRefGoogle Scholar
  6. 6.
    Ikeda T, Pignatelli M, Lever AML, et al. Relationship of HLA protein display to activation of 2–5 A synthetase in HBe antigen of anti-HBe positive chronic HBV infection. Gut 1986;27:1498–1501.PubMedCrossRefGoogle Scholar
  7. 7.
    Mondelli M, Vergani MG, Alberti A, et al. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol 1982;129: 2773–2778.PubMedGoogle Scholar
  8. 8.
    Naumov NV, Mondelli M, Allexander GHM, et al. Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection. Hepatology 1984;4:63–68.PubMedGoogle Scholar
  9. 9.
    Ferrari C, Penna A, Guiberti T, et al. Intrahepatic nucleocapsid antigen-specific T cells in chronic active hepatitis. J Immunol 1987;139:2050–2058.PubMedGoogle Scholar
  10. 10.
    Chu CM, Shyu WC, Kuo RW, et al. HLA calss I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: its role in the pathogenesis of chronic type N hepatitis. Hepatology 1987;7:1311–1316.CrossRefGoogle Scholar
  11. 11.
    Kato Y, Nagaoka H, Kobayashi K, et al. Interferon production by peripheral lymphocytes in HBsAg-positive liver disease. Hepatology 1982;2:789–790.PubMedGoogle Scholar
  12. 12.
    Ikeda T, Lever AML, Thomas HC. Evidence for a deficiency of interferon production by peripheral lymphocytes in HBsAg-positive liver diseases. Hepatology 1986;6:962–965.PubMedCrossRefGoogle Scholar
  13. 13.
    Fuji A, Kakumu S, Ohtani Y, et al. Interferon-γ production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1987;7:577–581.PubMedCrossRefGoogle Scholar
  14. 14.
    Inoue M, Kakumu S, Yoshioka K, et al. Hepatitis B core antigenspecifc IFN-γ production of peripheral blood mononuclear cells in patients with hepatitis B virus infection. J Immunol 1989;142: 4006–4011.PubMedGoogle Scholar
  15. 15.
    Daniels HM, Meager A, Eddieston ALWF, et al. Spontaneous production of tumor necrosis factor α and interleukin-1β during interferon-α treatment of chronic HBV infection. Lancet 1990; 335:875–877.PubMedCrossRefGoogle Scholar
  16. 16.
    Muller C, Zielinski CC. Impaired lipopolysaccharide-inducible tumor necrosis factor production in vitro by peripheral blood monocytes of patients with viral hepatitis. Hepatology 1990;12: 1118–1124.PubMedCrossRefGoogle Scholar
  17. 17.
    Nakabayashi H, Taketa K, Miyano K, et al. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 1982;42:3858–3863.PubMedGoogle Scholar
  18. 18.
    Towata T, Hayashi N, Katayama K, et al. Signal transduction pathways in the induction of HLA class I antigen expression on Huh6 cells by interferon-gamma. Biochem Biophys Res Commun 1991; 177:610–618.PubMedCrossRefGoogle Scholar
  19. 19.
    Takehara T, Hayashi N, Katayama K, et al. Enhanced expression of HLA class I by inhibited replication of hepatitis B virus. J Hepatol 1992 (in press).Google Scholar
  20. 20.
    Tsurimoto Y, Fujiyama A, Matsubara K. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci USA 1987;84;444–448.PubMedCrossRefGoogle Scholar
  21. 21.
    Onji M, Lever AML, Saito I, et al. Defective response to interferons in cells transfected with the hepatitis B virus genome. Hepatology 1989;9:92–96.PubMedCrossRefGoogle Scholar
  22. 22.
    Maudsley DJ, Pound JD. Modulation of MHC antigen expression by viruses and oncogenes. Immunology Today 1991;12:429–431.PubMedCrossRefGoogle Scholar
  23. 23.
    Zhou DX, Taraboulos A, Ou JH, et al. Activation of class I major histocompatibility complex gene expression by hepatitis B virus. J Virol 1990;64:4025–4028.PubMedGoogle Scholar
  24. 24.
    Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interaction. Science 1991;252:842–844.PubMedCrossRefGoogle Scholar
  25. 25.
    Unger T, Shaul Y. The X-protein of the hepatitis B virus acts as a transcription factor when targeted to its respoinsive elements. EMBO J 1990;9:1889–1895.PubMedGoogle Scholar
  26. 26.
    Seto E, Mitchell PJ, Yen TSB. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 1990;344:72–74.PubMedCrossRefGoogle Scholar
  27. 27.
    David-Watine B, Israel A, Kourilsky P. The regulation and expression of MHC class I genes. Immunology Today 1990;11:286–292.PubMedCrossRefGoogle Scholar
  28. 28.
    Nishizuka Y The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984;308:693–697.PubMedCrossRefGoogle Scholar
  29. 29.
    Berridge MJ, Irvine RF. Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 1984;312:315–321.PubMedCrossRefGoogle Scholar
  30. 30.
    Chung WY. Calmodulin plays a pivotal role in cellular regulation. Science 1980;207:19–27.CrossRefGoogle Scholar
  31. 31.
    Hidaka H, Inagaki M, Kawamoto S, et al. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 1984;23:5036–5401.PubMedCrossRefGoogle Scholar
  32. 32.
    Foster GR, Ackrill AM, Goldwin RD, et al. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons α and γ and double-stranded RNA. Proc Natl Acad Sci USA 1991;88:2888–2892.PubMedCrossRefGoogle Scholar
  33. 33.
    Erusalimsky JD, Kefford RF, Gilmore DJ, et al. Phorbol esters potentiate the induction of class IHLA expression by interferon α. Proc Natl Acad Sci USA 1989;86:1973–1976.PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society of Gastroenterology 1993

Authors and Affiliations

  • Takahiro Towata
    • 1
  • Norio Hayashi
    • 1
  • Kazuhiro Katayama
    • 1
  • Tetsuo Takehara
    • 1
  • Eiji Miyoshi
    • 1
  • Yuko Kawanishi
    • 1
  • Keiji Ueda
    • 1
  • Akinori Kasahara
    • 1
  • Hideyuki Fusamoto
    • 1
  • Takenobu Kamada
    • 1
  1. 1.First Department of MedicineOsaka University Medical SchoolOsakaJapan

Personalised recommendations